Results 21 to 30 of about 70,680 (286)
SAFETY OF BIOLOGICAL PREPARATIONS AND SMALL MOLECULES. ARE THERE ANY DIFFERENCES?
Педиатрическая фармакология, 2013 A considerable number of biopharmaceuticals have recently been introduced into clinical practice. Their role is becoming more and more important in managing various diseases, including incapacitating and life-threatening diseases.
A. S. Kolbin, A. V. Kharchev
doaj +1 more source
VertigO, 2009 During the years 1980’s, the Canadian government decided to stimulate the development of biotechnologies in order to become a leader in this sector.
Marie-Hélène Bacon
doaj +1 more source
Molecules, 2020 Adoptive cell therapy is an emerging anti-cancer modality, whereby the patient’s own immune cells are engineered to express T-cell receptor (TCR) or chimeric antigen receptor (CAR).
Camille Lombard-Banek, John E. Schiel
doaj +1 more source
Frontiers in Plant Science, 2022 Glycoproteins are the dominant category among approved biopharmaceuticals, indicating their importance as therapeutic proteins. Glycoproteins are decorated with carbohydrate structures (or glycans) in a process called glycosylation.
Alex van der Kaaij +4 more
doaj +1 more source
Whole-cell Escherichia coli lactate biosensor for monitoring mammalian cell cultures during biopharmaceutical production [PDF]
, 2017 Many high-value added recombinant proteins, such as therapeutic glycoproteins, are produced using mammalian cell cultures. In order to optimise the productivity of these cultures it is important to monitor cellular metabolism, for example the utilisation
Ainsworth, C +5 more
core +1 more source
A case report of telitacicept in the treatment of immunocompromised and refractory lupus nephritis
Frontiers in ImmunologyLupus nephritis (LN) is a manifestation of kidney damage in systemic lupus erythematosus and is more common in Asian populations. The standard-of-care (SOC) for LN includes antimalarials, glucocorticoids, and immunosuppressants.
Yongda Lin +3 more
doaj +1 more source
Benchmarking biopharmaceutical process development and manufacturing cost contributions to R&D
mAbs, 2020 This study aims to benchmark and analyze the process development and manufacturing costs across the biopharmaceutical drug development cycle and their contribution to overall research and development (R&D) costs.
Suzanne S. Farid +4 more
doaj +1 more source
Biopharmaceutical benchmarks 2022
Nature Biotechnology, 2022 Monoclonal antibodies as a group continue to lead biopharmaceuticals in numbers of approvals and sales, although COVID-19 vaccines shot to the top of the list of highest-grossing individual products.
Walsh, Gary, Walsh, Eithne
openaire +2 more sources
DEVELOPMENT PROSPECTS OF BIOPHARMACEUTICAL PLANTS IN PALEMBANG CITY
Biovalentia: Biological Research Journal, 2021 Biopharmaceutical plants or medicinal plants are plants grown in the garden that have medicinal properties. The types of biopharmaceutical plants have been cultivated for more than 5 years and are managed by the people of Palembang City who are members ...
Meri Ariyantini +2 more
doaj +1 more source
Locust bean gum: exploring its potential for biopharmaceutical applications [PDF]
, 2012 Polysaccharides have been finding, in the last decades, very interesting and useful applications in the biomedical and, specifically, in the biopharmaceutical field.
Dionísio, Marita, Grenha, Ana
core +2 more sources